No but there is a fair prospect of success. Currently sitting at close to zero enterprise value with the real prospect of commencing a phase3 HD registration trial within in short time. Phase3- Zero value. What is success? Just to start a trial could mean a 100% jump in price without any new clinical evidence, apart from the reams of preclinical and human trial data they have to date. IMO the next chance of "success" is the EMA answer on a HD phase3 trial.
Ann: Prana provides regulatory update for PBT2-PBT.AX, page-49
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122248 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 25307592 | 14 |
View Market Depth
| Last trade - 15.57pm 16/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable